scholarly journals High frequency of G to A transition mutation in the stromal cell derived factor-1 gene in India, a chemokine that blocks HIV-1 (X4) infection: multiple proteins bind to 3′-untranslated region of SDF-1 RNA

2001 ◽  
Vol 2 (7) ◽  
pp. 408-410 ◽  
Author(s):  
N Ramamoorti ◽  
J Kumarvelu ◽  
GK Shanmugasundaram ◽  
K Rani ◽  
AC Banerjea
AIDS ◽  
2001 ◽  
Vol 15 (14) ◽  
pp. 1890-1892 ◽  
Author(s):  
Anuska Llano ◽  
Jordi Barretina ◽  
Julià Blanco ◽  
Arantxa Gutiérrez ◽  
Bonaventura Clotet ◽  
...  

AIDS ◽  
1998 ◽  
Vol 12 (9) ◽  
pp. F85-F90 ◽  
Author(s):  
Ronald P. van Rij ◽  
Silvia Broersen ◽  
Jaap Goudsmit ◽  
Roel A. Coutinho ◽  
Hanneke Schuitemaker

1998 ◽  
Vol 95 (12) ◽  
pp. 6941-6946 ◽  
Author(s):  
C. Dealwis ◽  
E. J. Fernandez ◽  
D. A. Thompson ◽  
R. J. Simon ◽  
M. A. Siani ◽  
...  

Blood ◽  
1999 ◽  
Vol 94 (1) ◽  
pp. 62-73 ◽  
Author(s):  
Alessandro Aiuti ◽  
Lucia Turchetto ◽  
Manuela Cota ◽  
Arcadi Cipponi ◽  
Andrea Brambilla ◽  
...  

Human CD34+ hematopoietic progenitor cells obtained from bone marrow (BM), umbilical cord blood (UCB), and mobilized peripheral blood (MPB) were purified and investigated for the expression of the chemokine receptor CXCR4 and its ligand, stromal cell–derived factor-1 (SDF-1). CXCR4 was found present on the cell surface of all CD34+ cells, although it was expressed at lower density on MPB with respect to BM CD34+ cells. Freshly isolated and in vitro–cultured CD34+ cells also coexpressed SDF-1 mRNA, as determined by reverse transcriptase-polymerase chain reaction (RT-PCR). Of interest, CD34+/CD38+ committed progenitor cells, unlike primitive CD34+/CD38− cells, expressed SDF-1 mRNA. Supernatants from in vitro–cultured CD34+ cells contained substantial (3 to 8 ng/mL) amounts of SDF-1 by enzyme-linked immunosorbent assay and induced migration of CD34+ cells. Because CD34+ cells express low levels of CD4, the primary receptor of the human immunodeficiency virus (HIV), and CXCR4 is a coreceptor for T-cell tropic (X4) HIV strains, we investigated the susceptibility of CD34+cells to infection by this subset of viruses. Lack of productive infection was almost invariably observed as determined by a conventional RT activity in culture supernatants and by real-time PCR for HIV DNA in CD34+ cells exposed to both laboratory adapted (LAI) and primary (BON) X4 T-cell tropic HIV-1 strain. Soluble gp120 Env (sgp120) from X4 HIV-1 efficiently blocked binding of the anti-CD4 Leu3a monoclonal antibody (MoAb) to either human CD4+ T cells or CD34+ cells. In contrast, sgp120 interfered with an anti-CXCR4 MoAb binding to human T lymphocytes, but not to CD34+ cells. However, CXCR4 on CD34+ cells was downregulated by SDF-1. These results suggest that CXCR4 and its ligand SDF-1 expressed in CD34+ progenitors may play an important role in regulating the local and systemic trafficking of these cells. Moreover, these findings suggest multiple and potentially synergistic mechanisms at the basis of the resistance of CD34+ cells to X4 HIV infection, including their ability to produce SDF-1, and the lack of CXCR4 internalization following gp120 binding to CD4.


Intervirology ◽  
2015 ◽  
Vol 58 (6) ◽  
pp. 357-362 ◽  
Author(s):  
Jesús Salvador Velarde-Félix ◽  
Silvestre Guadalupe Cázarez-Salazar ◽  
Sylvia Páz Díaz-Camacho ◽  
Ignacio Osuna-Ramírez ◽  
Luis Antonio Ochoa-Ramírez ◽  
...  

2009 ◽  
Vol 84 (5) ◽  
pp. 2563-2572 ◽  
Author(s):  
Jeffrey D. Altenburg ◽  
Qingwen Jin ◽  
Bashar Alkhatib ◽  
Ghalib Alkhatib

ABSTRACT We previously demonstrated that the naturally occurring splice variant stromal cell-derived factor 1γ/CXCL12γ is the most potent CXCL12 isoform in blocking X4 HIV-1, with weak chemotactic activity. A conserved BBXB domain (B for basic and X for any residue) located in the N terminus (24KHLK27) is found in all six isoforms of CXCL12. To determine whether the potent antiviral activity of CXCL12γ is due to the presence of the extra C-terminal BBXB domains, we mutated each domain individually as well as in combination. Although binding of CXCL12γ to heparan sulfate proteoglycan (HSPG) was 10-fold higher than that observed with CXCL12α, the results did not demonstrate a direct correlation between HSPG binding and the potent antiviral activity. CXCL12γ mutants lacking the conserved BBXB domain (designated γB1) showed increased binding to HSPG but reduced anti-HIV activity. In contrast, the mutants lacking the C-terminal second and/or third BBXB domain but retaining the conserved domain (designated B2, B3, and B23) showed decreased binding to HSPG but increased anti-HIV activity. The B2, B3, and B23 mutants were associated with enhanced CXCR4 binding, receptor internalization, and restored chemotaxis. Internalization of CXCR4 was more potent with CXCL12γ than with CXCL12α and was significantly reduced when the conserved BBXB domain was mutated. We concluded that the observed potent anti-HIV-1 activity of CXCL12γ is due to increased affinity for CXCR4 and to efficient receptor internalization.


FEBS Letters ◽  
1998 ◽  
Vol 432 (1-2) ◽  
pp. 73-76 ◽  
Author(s):  
Paul Proost ◽  
Sofie Struyf ◽  
Dominique Schols ◽  
Christine Durinx ◽  
Anja Wuyts ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document